Skip to main content

Rubicon Organics Inc(ROMJ-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Rubicon Organics Inc down on Thursday (ROMJ)

Automated Summaries - The Globe and Mail - Thu Apr 18, 4:02PM CDT

Rubicon Organics Inc opened trading today at $0.38 and closed at $0.37. It traded at a low of $0.36 to a high of $0.38.

Shares dipped -1.33 percent from the previous day's close of $0.38.

Today across North America, the TSX Composite closed tsx_percentage_change% at 21708.44, the S&P 500 closed sp_500_percentage_change% at 5022.21, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37753.31 and the Nasdaq Composite closed nasdaq_percentage_change% at 15683.37.

Rubicon Organics Inc traded under ROMJ on the Toronto Venture Exchange (TSX-V).

A total of 23,680 shares was traded during the session, with total trades of 14. On average, Rubicon Organics Inc has traded 31,001 shares over the last 5-days and 20,435 year-to-date.

Trading across the entire TSX-V saw 2,663 price advancers against 2,504 declines and 146 unchanged.

During the prior 52 weeks, ROMJ.VN has traded as high as $0.64 (November 14,2023) and low as $0.33 (November 03,2023). Moreover, in the last 52 weeks, Rubicon Organics Inc's shares have reduced -38.33%, while this year, they have shrunken -26.00%.

Following today's trading, Rubicon Organics Inc has a market capitalization of $21.07 million on a float of 56,192 shares outstanding. Its annual EPS is $None.

Rubicon Organics Inc is a TSX Drug Specialty & Generic company headquartered in Vancouver, CAN.

Currently, Rubicon Organics Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe